Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administration
Authors:
- 27 February 2008
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 31 (2) , 87-94
Abstract
The pharmacokinetic properties of pradofloxacin and doxycycline were investigated in serum, saliva, and tear fluid of cats. In a crossover study design, six cats were treated orally with a single dose of pradofloxacin (Veraflox® Oral Suspension 2.5%) and doxycycline (Ronaxan® 100 mg) at 5 mg/kg body weight. Following administration, samples of serum, saliva, and tear fluid were taken in regular intervals over a period of 24 h and analysed by turbulent flow chromatography/tandem mass spectrometry. All values are given as mean ± SD. Pradofloxacin reached a mean maximum serum concentration (Cmax) of 1.1 ± 0.5 μg/mL after 1.8 ± 1.3 h (tmax). In saliva and tear fluid, mean Cmax was 6.3 ± 7.0 and 13.4 ± 20.9 μg/mL, respectively, and mean tmax was 0.5 ± 0 and 0.8 ± 0.3 h, respectively. Doxycycline reached a mean Cmax in serum of 4.0 ± 0.8 μg/mL after 4.3 ± 3.2 h. Whilst only at two time‐points doxycycline concentrations close to the limit of quantification were determined in tear fluid, no detectable levels were found in saliva. The high concentrations of pradofloxacin in saliva and tear fluid are promising to apply pradofloxacin for the treatment of conjunctivitis and upper respiratory tract infections in cats. As doxycycline is barely secreted into these fluids after oral application the mechanisms of its clinical efficacy remain unclear.Keywords
This publication has 46 references indexed in Scilit:
- Danofloxacin‐mesylate is a substrate for ATP‐dependent efflux transportersBritish Journal of Pharmacology, 2007
- Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheepJournal of Veterinary Pharmacology and Therapeutics, 2006
- Growth Cycle-Dependent Pharmacodynamics of Antichlamydial DrugsAntimicrobial Agents and Chemotherapy, 2005
- The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibioticsResearch in Veterinary Science, 2002
- Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco‐2) cellsBritish Journal of Pharmacology, 2002
- Comparison of the Polymerase Chain Reaction and Culture for the Detection of Feline Chlamydia psittaci in Untreated and Doxycycline-Treated Experimentally Infected CatsJournal of Veterinary Internal Medicine, 1999
- Challenges to Antibiotic Activity in TissueClinical Infectious Diseases, 1994
- Doxycycline binding to plasma albumin of several speciesJournal of Veterinary Pharmacology and Therapeutics, 1989
- Clinical Significance of Antibiotic Tissue PenetrationClinical Pharmacokinetics, 1989
- Pharmacokinetic Disposition of Quinolones in Human Body Fluids and TissuesClinical Pharmacokinetics, 1989